Two high-profile members of South Carolina’s Congressional delegation made news this week, as each made bold political statements on topics that President Donald Trump has put near the top of his ...
Cantor Fitzgerald upgraded shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) from a neutral rating to an overweight rating in a research note published on Wednesday morning, Marketbeat reports.